Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II NGR-hTNF monotherapy in previously treated colorectal cancer
2006-005451-15Phase 2Active
- Sponsor
- MolMed
- Start
- Jan 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of NGR-TNF in colorectal cancer (CRC), sponsored by MolMed. Primary endpoint: Progression-free survival. Started Jan 2007; status: active.
02
Drugs
NGR-TNF
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2006-005451-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005451-15.